New Delhi: Around 160 vaccines currently are being developed for COVID-19, and 25 of these are in human trial phases, according to the World Health Organization (WHO). These include Zydus and Bharat Biotech from India. Globally, leading the race are Moderna Inc and Oxford-AstraZeneca vaccines.
Moderna on Monday started phase-III human trials in the US. The earlier mover has completed phase-I and phase-II trials and is currently testing the vaccine on 30,000 volunteers. The mRNA-1273 vaccine will be given in two shots, 28 days apart.
The phase III will test the effectiveness of the vaccine. Technically, phase III will be completed in October 2022. However, considering the current pandemic situation, it will be simultaneously launched commercially depending on the preliminary data, sources said.
Also Read: Oxford COVID-19 Vaccine: Five Sites In India Ready For Final Human Trials
Also Read: Good News! Oxford Vaccine Shows Immune Response
Balasore: A young man was allegedly beaten to death on the suspicion of having committed…
Mumbai: Bollywood celebrities have often had funny, at times bizarre experiences, mostly involving hero-worshipping, demanding fans.…
Bhubaneswar: Police have arrested the owner of a Jatra (theatre) group for allegedly duping an…
Sanskriti Talwar Faridkot (Punjab): For the third consecutive year, Balwinder Singh of Mallan village in…
Bhubaneswar: Rain may play spoilsport in Christmas and New Year celebrations in Odisha as the…
New Delhi: Netflix showed the way, Amazon Prime Video is following in their footsteps. Come…
This website uses cookies.